Prostate Cancer Clinical Trials in Albuquerque, NM

Prostate Cancer Clinical Trials in Albuquerque, NM

View the best 10 prostate cancer medical studies in Albuquerque, New Mexico. Access promising new therapies by applying to a Albuquerque-based Prostate Cancer clinical trial.

Trials in Albuquerque, New Mexico

Here are the top 10 medical studies for prostate cancer in Albuquerque, New Mexico

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: August 8th, 2024

Image of Research Site in Tucson, United States.

AZD5305 +1 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial is testing a new drug called Saruparib combined with hormone treatment in adults with prostate cancer that has spread but still responds to hormones. The drug aims to stop cancer cells from repairing themselves, potentially slowing down the disease.
Image of Arizona in Phoenix, United States.

PT-112 Injection

Chemotherapy

Recruiting1 awardPhase 2
This trial is testing a new cancer drug, PT-112. It is in two parts, the first of which has finished enrolling. The second part is testing PT-112's safety and how well it works in patients with thymoma or thymic carcinoma, and in patients with metastatic castrate-resistant prostate cancer.
Image of Arizona Center for Cancer Care - Gilbert in Gilbert, United States.

ProstAtak® Immunotherapy

Cancer Vaccine

Recruiting1 awardPhase 3
This trial is testing ProstAtak® immunotherapy with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak® kills cancer cells and helps the immune system learn to attack any remaining cancer cells, potentially improving treatment outcomes.
Image of Memorial Sloan Kettering Basking Ridge in Basking Ridge, United States.

External Beam Radiotherapy

Radiation

Recruiting1 awardPhase 3
This trial is testing darolutamide, a new drug added to standard hormone therapy, in men with high-risk localized prostate cancer undergoing radiation. The goal is to see if this combination can better prevent the cancer from coming back and spreading compared to current treatments. Darolutamide works by blocking male hormones that help cancer grow, potentially reducing death rates from prostate cancer.
Image of Decatur Memorial Hospital in Decatur, United States.

Relugolix +1 More

Hormone Therapy

Recruiting0 awardsPhase 2
This trial is testing whether a drug that lowers testosterone levels combined with radiation therapy can shrink tumors in patients with prostate cancer that has spread to 1 to 5 other parts of the body.
Image of NCT01946204 in Birmingham, United States.

Apalutamide

Antiandrogen

Recruiting1 awardPhase 3
This trial will test whether apalutamide can help treat prostate cancer that is not responding to hormone therapy and has not spread.
Image of Veterans Administration Medical Center - Birmingham in Birmingham, United States.

TAK-700 +1 More

Androgen Synthesis Inhibitor

Recruiting2 awardsPhase 3
This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.
Image of NEA Medical Clinic - East Matthews in Jonesboro, United States.

Abiraterone Acetate +1 More

Antiandrogen

Recruiting1 awardPhase 2
This trial is studying abiraterone acetate to see if it can help treat patients with prostate cancer who have undergone initial hormone therapy.
Image of Moffitt Cancer Center & Research Institute Inc. in Tampa, United States.

Green Tea

Cancer Preventive Agent

Recruiting0 awardsPhase 2
This trial looks at whether green tea catechins can prevent prostate cancer from progressing in men who are being closely monitored for the disease.
Image of Stanford Cancer Institute Palo Alto in Palo Alto, United States.

Bicalutamide

Hormone Therapy

Recruiting1 awardPhase 2
This trial is testing bicalutamide with or without Akt inhibitor MK2206 to see if it's effective in treating prostate cancer in patients who have been treated before.

Popular Filters

Age 65+
Phase 3
< 50 mile distance
No Placebo

Phase 3 Trials

Birmingham, Alabama

Antiandrogen

Apalutamide for Castration-Resistant Prostate Cancer

Recruiting1 awardPhase 3
Albuquerque, New Mexico
This trial will test whether apalutamide can help treat prostate cancer that is not responding to hormone therapy and has not spread.
Birmingham, Alabama

Androgen Synthesis Inhibitor

TAK-700 vs. Bicalutamide for Prostate Cancer

Recruiting2 awardsPhase 3
Durango, Colorado
This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.
Gilbert, Arizona

Cancer Vaccine

ProstAtak® Immunotherapy + Radiation for Prostate Cancer

Recruiting1 awardPhase 3
Albuquerque, New Mexico
This trial is testing ProstAtak® immunotherapy with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak® kills cancer cells and helps the immune system learn to attack any remaining cancer cells, potentially improving treatment outcomes.
Birmingham, Alabama

Hormone Therapy

Radiation + Androgen-Deprivation Therapy for Prostate Cancer

Recruiting4 awardsPhase 3
Grand Junction, Colorado
This trial is comparing radiation therapy alone to radiation therapy with androgen-deprivation therapy to see which is more effective in treating prostate cancer.
Birmingham, Alabama

Radiation Therapy

Radiation Therapy + Androgen Deprivation for Prostate Cancer

Recruiting2 awardsPhase 3
Pueblo, Colorado
This study is evaluating whether radiation therapy is more effective than short-term androgen deprivation therapy for prostate cancer.
Anchorage, Alaska

Chemotherapy + Hormone Therapy With Surgery for Prostate Cancer

Recruiting4 awardsPhase 3
Montrose, Colorado
This trial is comparing docetaxel given before surgery to surgery alone in treating patients with high-risk localized prostate cancer to see if it is more effective.

Trials With No Placebo

Birmingham, Alabama

Kinase Inhibitor

Targeted Therapy for Cancer

Recruiting1 awardPhase 2
Scottsdale, Arizona
This trial uses genomic testing to direct cancer treatment. Patients with cancer that has progressed after standard treatment or for which there is no agreed-upon treatment may benefit.
Phoenix, Arizona

Chemotherapy

PT-112 Injection for Advanced Prostate Cancer

Recruiting1 awardPhase 2
Albuquerque, New Mexico
This trial is testing a new cancer drug, PT-112. It is in two parts, the first of which has finished enrolling. The second part is testing PT-112's safety and how well it works in patients with thymoma or thymic carcinoma, and in patients with metastatic castrate-resistant prostate cancer.
Birmingham, Alabama

Androgen Synthesis Inhibitor

TAK-700 vs. Bicalutamide for Prostate Cancer

Recruiting2 awardsPhase 3
Durango, Colorado
This trial is testing if a new drug called TAK-700 helps people with prostate cancer live longer than another drug called bicalutamide when used with ADT.
Jonesboro, Arkansas

Antiandrogen

Abiraterone + Prednisone for Prostate Cancer

Recruiting1 awardPhase 2
Alamosa, Colorado
This trial is studying abiraterone acetate to see if it can help treat patients with prostate cancer who have undergone initial hormone therapy.
Palo Alto, California

Hormone Therapy

Bicalutamide + MK2206 for Prostate Cancer

Recruiting1 awardPhase 2
Pueblo, Colorado
This trial is testing bicalutamide with or without Akt inhibitor MK2206 to see if it's effective in treating prostate cancer in patients who have been treated before.
Birmingham, Alabama

Hormone Therapy

Radiation + Androgen-Deprivation Therapy for Prostate Cancer

Recruiting4 awardsPhase 3
Grand Junction, Colorado
This trial is comparing radiation therapy alone to radiation therapy with androgen-deprivation therapy to see which is more effective in treating prostate cancer.

View More Related Trials

Intensity-Modulated Radiation Therapy (IMRT) +1 More

Hypofractionated radiation therapy

LHRH Analogue +3 More

KPT-8602

lutetium Lu 177 vipivotide tetraxetan +1 More

Relugolix +1 More

Datopotamab deruxtecan (Dato-DXd)

Darolutamide +1 More

Relugolix +1 More

XmAb20717

abiraterone decanoate +3 More

177Lu-PSMA-617 +2 More

[Lu-177]-PNT2002

Green Tea

AZD5305 +1 More

View more prostate-cancer clinical trials albuquerque

See more medical studies focusing on prostate-cancer albuquerque

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top